G Lafuente-Gómez, F Anaya-Fernández Lomana, A Gómez-Roldós, J M García-Domínguez, A Lozano-Ros, J P Cuello, Y Higueras-Hernández, A Meldaña-Rivera, H Goicochea-Briceño, R Leal-Hidalgo, C J De Miguel-Sánchez de Puerta, M L Martínez-Ginés
INTRODUCTION: Relapsing-remitting multiple sclerosis (RRMS) treatment has significantly changed in recent years because of the discovery of new molecules that have shown efficacy as maintenance treatment. However, the classical treatment for acute attacks is based on corticosteroids administration, being the periodical plasmapheresis the alternative treatment in the case of refractory patients. We introduce a case of relapsing-remitting multiple sclerosis treated with a classical acute attacks therapy: plasmapheresis...
May 16, 2022: Revista de Neurologia